Research and innovation areas


  • Banner photo

    Coronavirus: the Commission proposes strong support and faster procedures for new therapeutics

    The European Commission is complementing the successful EU strategy for COVID-19 vaccines with a strategy on COVID-19 therapeutics, covering the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment. The aim is to support the development and to increase the availability of much-needed COVID-19 therapeutics. The Commission also adopted a legislative proposal for an emergency use authorisation at EU level to provide faster access to medicinal products in a public health emergency. Factsheet on therapeutics projects.


DownloadPDF - 1.2 MB
DownloadPDF - 1.2 MB
DownloadPDF - 288.3 KB
DownloadPDF - 294.6 KB